Aims To determine the demographic and morphological characteristics of patients with central serous chorioretinopathy (CSC) and describe risk factors for CSC.
Methods We retrospectively reviewed medical records of 811 patients with CSC and 816 healthy controls referred from 2002 to 2018.
Results The female/male ratio of patients with CSC was 1/2.7. Mean age of onset was 45.2 years. The peak prevalence for men occurred at 45–49 years. Women had two prevalence peaks, the higher at 55–59 years and the other at 45–49 years. Of these patients, 56.8% had unilateral disease, 42.1% had bilateral disease and 1.1% had only one eye. 671 (82.7%) patients had spectral domain optical coherence tomography (SD-OCT) images and 598 (73.7%) had enhanced depth choroidal images. Pigment epithelial detachment (PED) was detected in 763 (80.7%) of 945 eyes with SD-OCT images. Chronic cases were more likely to be bilateral and multifocal and to have PED (all p<0.001). Subfoveal choroidal thickness (SFCT) did not differ between chronic and classic cases (p=0.74), but SFCT was greater in multifocal cases than unifocal cases (p<0.001). In multivariate regression analyses, older age of onset, longer duration of disease and hyperopia were positively associated with having chronic disease rather than classic disease, and myopia and thyroid hormone replacement were negatively associated. Steroid use, antidepressant or anxiolytic drug use, smoking, pregnancy and hyperopia were risk factors, and myopia was a protective factor for CSC.
Conclusion This is the largest case-control study of CSC to evaluate demographic morphological characteristics and risk factors. Multiple factors are associated with CSC.
- central serous chorioretinopathy
- choroidal thickness
- retinal pigment epithelium detachment
- risk factors
Statistics from Altmetric.com
Contributors MGE and MK were involved in the conception and design of the study. MGE, MK and SA were involved in the analysis, interpretation and critical revision of the article. MGE was involved in the drafting of the manuscript. MGE, MK, ISM, MH and SA were involved in the final approval of the article. MGE, ISM and MH were involved in the data collection and literature research.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Ethics approval The Institutional Review Board of Şişli Memorial Hospital, Istanbul.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The authors had full access to all the data in the study and take full responsibility for the integrity and the accuracy of the data as well as the decision to submit for publication. All authors approved the manuscript and its submission.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.